Articles by Marilyn Kochman - BioPharm International



Articles by Marilyn Kochman

Hylenex Accelerates Time to Peak Blood Concentration for Subcutaneous Morphine

Mar 22, 2007

Patients receiving palliative care in hospices, hospitals, and other settings can benefit from a subcutaneous injection of morphine with Hylenex recombinant (hyaluronidase human injection).

Salary Survey: Is Your Paycheck as Robust as Your Proteins?

BioPharm International's First Salary and Employee Satisfaction Survey
Jan 1, 2007

The biotechnology industry is thriving, and hopefully you are too. BioPharm International's first salary and employee satisfaction survey presents a wealth of data that will allow you to compare many aspects of your job with those of your peers. The survey reports on demographics, education, work experience, salary and benefits, and attitudes toward current employment.

New FDA Guidance Helps Industry Develop Cell-Based Viral Vaccines

Oct 26, 2006

The US Food and Drug Administration (FDA) issued a new guidance September 28 to help manufacturers develop safe and effective cell-based viral vaccines.

Fastest Drug Developers Outperform Peers

Sep 27, 2006

Drugs developed by the fastest companies each gained an average of $1.1 billion in incremental prescription revenue and saved an average of $30 million in out-of-pocket development costs, compared to those of the slowest companies, according to Tufts University's Center for the Study of Drug Development (CSDD).

Gamma Radiation Proves Effective in Vaccine Development

Aug 31, 2006

Vaccines made with bacteria killed by gamma rays may be more effective than those made using standard heat or chemical inactivation, according to Sandip Datta, MD, assistant professor in the department of medicine, University of California, San Diego (

Iontophoresis, Sonophoresis, and Microneedles Permit Effective Transdermal Delivery of Biologics

Jun 27, 2006

The transdermal delivery of biologics-as well as of conventional drugs-is growing in popularity because the technique offers numerous advantages.

How to Avoid Leachables, Extractables, and Other Hazards in Parenteral Packaging

Jun 27, 2006

On August 12, 2003, Johnson & Johnson began recalling certain batches of its anemia drug, Eprex (epoetin alfa, sold as Procrit in the US), in most countries outside of the United States.



Click here